LANCER ORTHODONTICS INC /CA/
10QSB, 2000-01-12
DENTAL EQUIPMENT & SUPPLIES
Previous: KROGER CO, 8-K, 2000-01-12
Next: VALHI INC /DE/, SC 13D/A, 2000-01-12




                       SECURITIES AND EXCHANGE COMMISSION

                              Washington DC 20549

                                  FORM 10-QSB

  Quarterly Report Under Section 13 or 15(d) of the Securities Exchange Act of
                                      1934

For Quarter Ended November 30, 1999                 Commission File No. 0-5920

                           LANCER ORTHODONTICS, INC.
       (Exact Name of Small Business Issuer as Specified in its Charter)

          CALIFORNIA                                         95-2497155
(State or Other Jurisdiction of                          (I.R.S. Employer
  Incorporation or Organization)                         Identification No.)

                253 Pawnee Street, San Marcos, California 92069
                    (Address of Principal Executive Offices)

Issuer's telephone number, including area code:                 (760) 744-5585

   Check whether the issuer:  (1) filed all reports required to be filed by
   Section 13 or 15(d) of the Securities Exchange Act during the preceding 12
   months (or for such shorter period that the Registrant was required to file
   such reports, and (2) has been subject to such filing requirements for the
   past 90 days.

            Yes       X                               No


<PAGE>

State the number of shares outstanding of each of the issuer's classes of common
equity, as of the latest practicable date:  2,018,291

Traditional small business disclosure format (check one):

            Yes       X                               No


PART I.     FINANCIAL INFORMATION

Item 1.     SUMMARIZED FINANCIAL INFORMATION

                           LANCER ORTHODONTICS, INC.
                      CONDENSED BALANCE SHEET (UNAUDITED)
                                    11/30/99

                                     ASSETS

CURRENT ASSETS:
     Cash                                                          $  128,498
     Accounts Receivable, less allowances for sales
        returns and doubtful receivables of $170,752                1,237,275
     Inventories                                                    2,224,411
     Prepaid Expenses                                                  31,280
        Total Current Assets                                        3,621,464

PROPERTY AND EQUIPMENT, at cost                                     2,396,227
     Less:  Accumulated depreciation                               (2,247,648)
                                                                      148,579
INTANGIBLE ASSETS:
     Marketing and Distribution Rights, net                           122,425
     Technology Use Rights, net                                       150,120
<PAGE>

                                                                      272,545
OTHER ASSETS                                                            6,560
        Total Assets                                               $4,049,148

                      LIABILITIES AND STOCKHOLDERS' EQUITY

CURRENT LIABILITIES:
     Accounts Payable and Accrued Liabilities                      $  627,309
     Line of Credit                                                   220,000
        Total Current Liabilities                                     847,309

COMMITMENTS AND CONTINGENCIES                                              --

STOCKHOLDERS' EQUITY:
     Redeemable Convertible Preferred Stock, Series C,
       $.06 noncumulative annual dividend; $.75 par value:
       Authorized 250,000 shares; no shares issued and outstanding
       ($.75 liquidation preference)                                       --
     Redeemable Convertible Preferred Stock, Series D,
       $.04 noncumulative annual dividend; $.50 par value:
       Authorized 500,000 shares; 370,483 issued and outstanding
       ($.50 liquidation preference:  aggregate liquidation
       preference of $185,242)                                        185,242
     Common Stock, no par value: Authorized 50,000,000 shares;
       issued and outstanding 2,018,291                             4,602,735
     Accumulated Deficit                                           (1,586,138)
        Total Stockholders' Equity                                  3,201,839
        Total Liabilities and Stockholders' Equity                 $4,049,148
                           LANCER ORTHODONTICS, INC.
                     CONDENSED STATEMENTS OF OPERATIONS AND
        CONDENSED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) (UNAUDITED)

<PAGE>

                                     FOR THE THREE           FOR THE SIX
                                     MONTHS ENDED            MONTHS ENDED
                                  11/30/99    11/30/98    11/30/99    11/30/98

NET SALES                       $1,387,370  $1,534,218  $2,658,914  $3,074,520

COST OF SALES                      864,587   1,022,298   1,765,669   1,963,574

     Gross Profit                  522,783     511,920     893,245   1,110,946

OPERATING EXPENSES:
     Selling, Gen & Admin          549,056     553,938   1,087,604   1,077,507
     Product Development            49,672      36,232     106,337      68,554

TOTAL OPERATING EXPENSES           598,728     590,170   1,193,941   1,146,061

INCOME (LOSS) FROM OPERATIONS (    75,945) (    78,250)(  300,696) (   35,115)

OTHER INCOME (EXPENSE):
     Interest Expense         (     4,466) (     2,629)(    8,171) (    4,608)
     Other Income (Exp), net  (     2,817)         919     167,585         787

TOTAL OTHER INCOME (EXP)      (     7,283) (     1,710)    159,414 (    3,821)

INCOME (LOSS) BEFORE
  INCOME TAXES                (    83,228) (    79,960)(  141,282) (   38,936)

  INCOME TAXES                          --          --         800         800

NET INCOME (LOSS)             (    83,228) (    79,960) (  142,082)(   39,736)

OTHER COMPREHENSIVE INCOME              --          --          --          --
<PAGE>


COMPREHENSIVE INCOME (LOSS)   $(   83,228 $(   79,960)$(  142,082)$(   39,736)


NET INCOME (LOSS) PER WEIGHTED AVERAGE OF COMMON SHARES

BASIC                          $     (.04)$     (.04)  $     (.07) $     (.02)

DILUTED                        $     (.04)$     (.04)  $     (.07) $     (.02)


                            LANCER ORTHODONTICS, INC.
                       CONDENSED STATEMENTS OF CASH FLOWS


                                                    FOR THE SIX MONTHS ENDED
                                                    11/30/99         11/30/98

CASH FLOWS FROM OPERATING ACTIVITIES:
     Net Loss                                      $(142,082)       $( 39,736)
     Adjustments to reconcile net income to net
        cash provided by (used in) operating activities:
        Depreciation and amortization                 75,409           81,439
        Provision for losses on accounts receivable (  5,234)        ( 20,882)
        Provision for losses on inventory             22,000           18,000
        Common stock issued for services to directors 23,170               --
        Net change in operating assets and liabilities:
           Accounts receivable                       119,679           14,879
           Inventories                              ( 39,257)        (363,980)
           Prepaid expenses                           20,565           49,037
           Insurance claim receivable                110,000               --
           Accounts payable and accrued liabilities ( 81,511)        ( 15,375)
<PAGE>


Net cash provided by (used in) operating activities  102,739         (276,618)


CASH FLOWS FROM INVESTING ACTIVITIES:
     Additions to property and equipment            (  2,983)        ( 42,120)

Net cash (used in) investing activities             (  2,983)        ( 42,120)

CASH FLOWS FROM FINANCING ACTIVITIES:
     Repurchase of common stock                     (117,550)        (  4,488)
     Line of credit                                   40,000          100,000

Cash flows used in financing activities             ( 77,550)          95,512


NET CHANGE IN CASH                                    22,206         (223,226)

Cash, beginning of period                            106,292          321,036

Cash, end of period                                 $128,498         $ 97,810





                           LANCER ORTHODONTICS, INC.

NOTES TO FINANCIAL STATEMENTS

(A) BASIS OF PRESENTATION

<PAGE>

The accompanying unaudited condensed financial statements have been prepared in
accordance with the instructions to Form 10-QSB and therefore do not include all
information and notes necessary for a fair presentation of financial position,
results of operations, and cash flows in conformity with generally accepted
accounting principles.  The unaudited condensed financial statements include the
accounts of Lancer Orthodontics, Inc. (the "Company").  The operating results
for interim periods are unaudited and are not necessarily an indication of the
results to be expected for the full fiscal year.  In the opinion of management,
the results of operations as reported for the interim periods reflect all
adjustments which are necessary for a fair presentation of operating results.

(B) ORGANIZATION

The Company was incorporated on August 25, 1967, in the state of California, for
the purpose of engaging in the design, manufacture, and distribution of
orthodontic products.  The Company has a manufacturing facility in Mexico where
a majority of its inventory is manufactured (Note I).  The Company also
purchases certain orthodontic and dental products for purposes of resale.  Sales
are made directly to orthodontists world-wide through Company representatives
and independent distributors.  The Company also sells certain of its products on
a private label basis.

(C) USE OF ESTIMATES IN THE PREPARATION OF FINANCIAL STATEMENTS

The preparation of financial statements in conformity with generally accepted
accounting principles ("GAAP"), requires management to make estimates and
assumptions that affect the reported amounts of assets and liabilities and the
disclosure of contingent assets and liabilities at the date of the financial
statements, and the reported amounts of revenues and expenses during the
reporting period.  Significant estimates made by the Company's management
include, but are not limited to, allowances for doubtful accounts, allowances
for sales returns, the valuation of inventories, and the realizeability of
<PAGE>

property and equipment through future operations.  Actual results could
materially differ from those estimates.

(D) STOCK BASED COMPENSATION

The Company accounts for stock based compensation under Statement of Financial
Accounting Standards No. 123 ("SFAS 123").  SFAS 123 defines a fair value based
method of accounting for stock based compensation.  However, SFAS 123 allows an
entity to continue to measure compensation cost related to stock and stock
options issued to employees using the intrinsic method of accounting prescribed
by Accounting Principles Board Opinion No. 25 ("APB 25"), "Accounting for Stock
Issued to Employees".  Entities electing to remain with the accounting method of
APB 25 must make pro forma disclosures of net income and earnings per share, as
if the fair value method of accounting defined in SFAS 123 had been applied.
The Company has elected to account for its stock based compensation to employees
under APB 25.

                           LANCER ORTHODONTICS, INC.

NOTES TO FINANCIAL STATEMENTS - continued

(E) INSURANCE CLAIM

Management of the Company completed an assessment of a theft of inventory
located at its facility in Mexicali, Mexico on April 6, 1999.  The carrying
value of the inventory stolen approximated $110,000, valued at standard cost,
which was reflected in the May 31, 1999 financial statements as a reduction in
inventories and an addition to insurance claim receivable.  In July 1999, the
Company settled the claim with the insurance carrier and received $279,672; the
value of the stolen inventory at net average selling price, less commissions and
royalties.  The Company recorded other income of $169,672 from the proceeds
received in excess of standard cost.
<PAGE>


(F) LINE OF CREDIT

At November 30, 1999, the Company had a $500,000 line of credit with a bank.
Borrowings are made at prime plus 1.25% (9.5% at November 30, 1999) and are
limited to specified percentages of eligible accounts receivable.  The unused
portion available under the line of credit at November 30, 1999 was $121,464.
The line of credit expires on November 3, 2000.

The line of credit is collateralized by substantially all the assets of the
Company, including inventories, receivables, and equipment.  The lending
agreement for the line of credit requires, among other things, that the Company
maintain a tangible net worth of $2,800,000 and a debt to tangible net worth
ratio of no more than 1 to 1.  The Company is not required to maintain
compensating balances in connection with this lending agreement.

(G) COMMITMENTS AND CONTINGENCIES

MANUFACTURING AGREEMENT - The Company has entered into a manufacturing
subcontractor agreement whereby, the subcontractor agreed to provide
manufacturing services to the Company through its affiliated entities located in
Mexicali, B.C., Mexico.  The Company has moved the majority of its manufacturing
operations to Mexico.  In December 1992, the Company renegotiated the agreement
changing from an hourly rate per employee to a pass through of actual costs plus
a weekly administrative fee.  The amended agreement gives the Company greater
control over all costs associated with the manufacturing operation.  In July
1994, the Company again renegotiated the agreement, reducing the administrative
fee.  Effective April 1, 1996, the Company leased  the Mexicali  facility  under
a  separate  arrangement.  In November  1998, the  Company extended the
Manufacturing Agreement through December 2003.  The Company has retained the
option to convert the manufacturing operation to a wholly-owned subsidiary at
any time.  Should the Company discontinue operations in Mexico, it is
<PAGE>

responsible for the accumulated employee seniority obligation as prescribed by
Mexican law.  At November 30, 1999, this obligation was approximately $258,000.
Such obligation is contingent in nature and accordingly has not been accrued in
the accompanying balance sheet.





                           LANCER ORTHODONTICS, INC.

NOTES TO FINANCIAL STATEMENTS - continued

(G) COMMITMENTS AND CONTINGENCIES _ continued

LEASES - The Company leases its main facility under a non-cancelable operating
lease expiring December 31, 2003, which requires monthly rental payments that
increase annually, from $2,900 per month in 1994 to $6,317 per month in 2003.
The Company also leases its Mexico facility under a non-cancelable operating
lease expiring October 2003, which requires average monthly rentals of
approximately $6,040.  The rentals are subject to annual increases based on the
United States Consumer Price Index.  Future aggregate minimum annual cash lease
payments are as follows:
                     Years ending
                     May 31, 2000                      $138,362
                     May 31, 2001                       140,994
                     May 31, 2002                       143,733
                     May 31, 2003                       146,587
                     Thereafter                          74,884
                          Total                        $644,560


<PAGE>

YEAR 2000 ISSUES _ Certain computerized systems use only two digits to record
the year in date fields.  Such systems may not be able to accurately process
dates ending in the year 2000 and after.  The effects of this issue will vary
from system to system and may adversely affect an entity's operations as well as
its ability to prepare financial statements.  The accounting and MRP software
for the Company'' main frame computer system has been upgraded to the year 2000
compliant and is actively supported by the developer.  The Company does not
anticipate to incur significant additional costs to be completely year 2000
compliant.

The Company does not place orders electronically nor does it make disbursements
to vendors or employees in that medium.  The Company has a broad base of
customers and suppliers and therefore is not heavily reliant on any one outside
company.  However, the Company has no way of completely knowing how the year
2000 may affect its various vendors or customers if such conversions are not
completed on a timely basis by them, and thus it cannot estimate with certainty
the impact the year 2000 may have on the Company.


(H) INCOME TAXES

At May 31, 1999, the Company had net tax operating loss carryforwards of
approximately $1,850,000 and business tax credits of approximately $150,000
available to offset future Federal taxable income and tax liabilities,
respectively.  The Federal carryforwards expire in varying amounts from 1999 to
2012.  As of May 31, 1999, the Company had business tax credits of approximately
$23,000 available to offset future state income tax liabilities.  The Company's
state net operating loss carryforward totaling approximately $255,000 expired
during the year ended May 31, 1998.



<PAGE>


                           LANCER ORTHODONTICS, INC.

NOTES TO FINANCIAL STATEMENTS - continued

(I) NET (LOSS) INCOME PER COMMON SHARE AND DIVIDENDS

The Company calculates earnings per share in accordance with Statement of
Financial Accounting Standards ("SFAS 128").  SFAS 128 replaces the presentation
of primary and fully diluted earnings per share with the presentation of basic
and diluted earnings per share.  Basic earnings per share excludes dilution and
is calculated by dividing income available to common stockholders  by  the
weighted-average  number  of  common  shares  outstanding for the period.

Diluted earnings per share reflects the potential dilution that could occur if
securities or other contracts to issue common stock were exercised or converted
into common stock or resulted in the issuance of common stock that then shared
in the earnings of the entity.  For all periods presented, no common stock
equivalents have been included in the computation of diluted earnings per share
as they were determined to be anti-dilutive.

                                            EARNINGS PER SHARE (UNAUDITED)
                                     FOR THE THREE          FOR THE NINE
                                     MONTHS ENDED            MONTHS ENDED
                                  11/30/99    11/30/98    11/30/99    11/30/98

      BASIC (LOSS) EARNINGS PER SHARE:

Net (loss) income             $(   83,228)$(   79,960)$(  142,082)$(   39,736)

Net (loss) income applicable to
      common shareholders     $(   83,228)$(   79,960)$(  142,082)$(   39,736)
<PAGE>


Weighted average number of
      common shares              2,049,059   2,117,040   2,062,502   2,117,663

Basic (loss) earnings per share$(      .04)$(      .04)$(      .07)$(      .02)

      DILUTED (LOSS) EARNINGS PER SHARE:

Net (loss) income from primary
      income per common share $(   83,228)$(   79,960)$(  142,082)$(   39,736)

Net (loss) income for diluted
      earnings per share      $(   83,228)$(   79,960)$(  142,082)$(   39,736)

Weighted average number of shares
      used in calculation of diluted
      earnings per share         2,049,059   2,117,040   2,062,502   2,117,663

Diluted (loss) earnings per share$(    .04)$(     .04) $(     .07) $(     .02)


                           LANCER ORTHODONTICS, INC.

NOTES TO FINANCIAL STATEMENTS - continued

(J) FINANCIAL INFORMATION ABOUT FOREIGN AND DOMESTIC OPERATIONS AND EXPORT SALES

                                                  FOR THE SIX MONTHS ENDED
                                                11/30/99            11/30/98
   Sales to unaffiliated customers:
         United States                         $1,659,302        $1,739,883
         Europe                                   568,011           740,362
<PAGE>

         South America                            171,951           285,828
         Other Foreign                            259,650           308,447
                                               $2,658,914        $3,074,520

   No other geographic concentrations exist where net sales exceed 10% of total
net sales.

   Sales or transfers between geographic areas       none              none

   Operating profit (loss):
         United States                         $(200,071)          $(63,120)
         Europe                                 ( 57,178)            15,534
         South America                          ( 17,309)             5,996
         Other Foreign                          ( 26,138)             6,475
                                               $(300,696)          $(35,115)

(K) STOCKHOLDERS' EQUITY

In March 1998, the Company's Board of Directors approved the repurchase of the
Company's outstanding common stock in the market place over twelve months.  In
June 1999, the repurchase was extended until May 2000.  During the six months
ended November 30, 1999, the Company repurchased and retired 114,969 shares of
its common stock for an aggregate consideration of $117,851.

The Company issued 27,295 new shares of its common stock valued at $23,170 for
directors fees previously outstanding and included in accrued liabilities as of
May 31, 1999.

                           LANCER ORTHODONTICS, INC.

NOTES TO FINANCIAL STATEMENTS - continued

<PAGE>

Item 2.     MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL    CONDITION AND
RESULTS OF OPERATIONS

Except for historical information contained herein, the statements in this Form
10-QSB are forward-looking statements that are made pursuant to the safe harbor
provisions of the Private Securities Litigation Reform Act of 1995.  Forward-
looking statements involve known and unknown risks and uncertainties which may
cause the Company's actual results in future periods to differ materially from
forecasted results.  These risks and uncertainties include, among other things,
the continued demand for the Company's products, availability of raw materials
and the state of the economy.  These and other risks are described in the
Company's Annual Report on Form 10-KSB and in the Company's other filings with
the Securities and Exchange Commission.

RESULTS OF OPERATIONS

For the six months ended November 30, 1999, net income decreased from a net loss
of $39,736 at November 30, 1998, to a net loss of $142,082 at November 30, 1999.
For the three months ended November 30, 1999, net income decreased from a net
loss of $79,960 at November 30, 1998, to a net loss of $83,228 at November 30,
1999.  The decrease in net income is primarily attributable to the decrease in
sales, offset by the insurance claim proceeds.

For the six months ended November 30, 1999, net sales decreased $415,606 (13.5%)
as compared to the year earlier period.  For the three months ended November 30,
1999, net sales decreased $146,848 (9.6%) as compared to the year earlier
period.  International net sales decreased $335,025 (25.1%) and $101,029
(15.2%), respectively, for the six months and three months ended November 30,
1999, as compared to the year earlier period.  This decrease is primarily
attributable to economic conditions in Europe and South America.  Domestic net
sales decreased $80,581 (4.6%) and $45,819 (5.3%), respectively, for the six
months and three months ended November 30, 1999, as compared to the year earlier
<PAGE>

period.  This decrease is primarily attributable to increased discounting due to
competition pressures.

For the six months ended November 30, 1999, cost of sales as a percentage of
sales (66.4%) increased 2.5% compared to the year earlier period.  For the three
months ended November 30, 1999, cost of sales as a percentage of sales (62.3%)
decreased 4.3% compared to the year earlier period.  The six months increase is
primarily attributable to fixed production costs not being absorbed into
inventory due to decreased demand.  The three months decrease is primarily
attributable to a decrease in production labor costs.  The Company is in the
process of developing improved manufacturing processes to reduce unit costs.

For the six months ended November 30, 1999, selling and general and
administrative expenses increased $10,097 (.9%) compared to the year earlier
period.  For the three months ended November 30, 1999, selling and general and
administrative expenses decreased $4,882 (.9%) as compared to the year earlier
period.  The six months increase is primarily attributable to an increase in
financial personnel and professional fees.



                           LANCER ORTHODONTICS, INC.

NOTES TO FINANCIAL STATEMENTS - continued

For the six months ended November 30, 1999, product development expenses
increased $37,783 (55.1%) as compared to the year earlier period.  For the three
months ended November 30, 1999, product development expenses increased $13,440
(37.1%) compared to the year earlier period.  The increase is primarily
attributable to development costs of an innovative dental amalgam.


<PAGE>

For the six months ended November 30, 1999, interest expense increased $3,563
(77.3%) as compared to the year earlier period.  For the three months ended
November 30, 1999, interest expense increased $1,837 (69.9%) as compared to the
year earlier period  The increase is attributable to borrowings against the line
of credit to finance development costs and an increase in the interest rate.

For the six months ended November 30, 1999, other income of $169,672 was
realized from the insurance claim settlement of $279,672 for the theft of
inventory at the Company's Mexicali facility, less $110,000 insurance claim
receivable valued at cost at May 31, 1999.

FINANCIAL CONDITION, LIQUIDITY, AND CAPITAL RESOURCES

The Company's financial condition at November 30, 1999 and its previous two
fiscal year ends was as follows:
                                       11/30/99       05/31/99       05/31/98
Current Assets                       $3,621,464     $3,827,011     $3,488,437
Current Liabilities                     847,309        888,820        684,222
Working Capital                       2,774,155      2,938,191      2,804,215
Bank Debt                               220,000        180,000        100,000
Shareholder Equity                    3,201,839      3,438,301      3,404,548
Total Assets                          4,049,148      4,327,121      4,088,770

Cash increased $22,206 during the six months ended November 30, 1999, primarily
due to the insurance claim settlement.

Working capital decreased $164,036 during the six months ended November 30,
1999, primarily attributable to a decrease in sales, partially offset by an
increase in inventories and cash.  The Company is currently considering
investing from $200,000 to $300,000 in replacement equipment.  Funds for this
investment will come from cash flow and new borrowings.  The Company expects to

<PAGE>

meet the rest of its cash requirements out of its cash reserves, cash flow, and
line of credit.

                           LANCER ORTHODONTICS, INC.

PART II.    OTHER INFORMATION

Item 1.     LEGAL PROCEEDINGS  Not Applicable

Item 2.     CHANGES IN SECURITIES  Not Applicable

Item 3.     DEFAULTS UPON SENIOR SECURITIES  Not Applicable

Item 4.     SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS

a.   The Company's 1999 annual meeting of shareholders was held on November 17,
1999.

b.   The following nominees were elected directors:
     Zackary Irani      Janet Moore       Douglas Miller      Robert Orlando

c.   Summary of voting for directors:

                                   For          Against       Abstentions
   Zackary Irani                 1,961,284         0             32,053
   Douglas Miller                1,961,312         0             32,025
   Janet Moore                   1,961,312         0             32,025
   Robert Orlando                1,961,312         0             32,025

   Total Response                1,993,337

   There were no broker non-votes.
<PAGE>


Item 5.     OTHER INFORMATION  Not Applicable

Item 6.     EXHIBITS AND REPORTS ON FORM 8-K

            There were no Form 8-k reports filed during the quarter.

                                   SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.


                                                LANCER ORTHODONTICS, INC.
                                                        Registrant



Date January 12, 2000                     By /s/ Douglas D. Miller
                                               Douglas D. Miller,
                                              President and Chief Operating
                                              Officer









<PAGE>


<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
This schedule contains summary financial information extracted from Lancer
Orthodontics, Inc.'s second quarter 10-Q and is qualified in its entirety by
reference to such 10-Q.
</LEGEND>

<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          MAY-31-2000
<PERIOD-END>                               NOV-30-1999
<CASH>                                         128,498
<SECURITIES>                                         0
<RECEIVABLES>                                1,408,027
<ALLOWANCES>                                 (170,752)
<INVENTORY>                                  2,224,411
<CURRENT-ASSETS>                             3,621,464
<PP&E>                                       2,396,227
<DEPRECIATION>                             (2,247,648)
<TOTAL-ASSETS>                               4,049,148
<CURRENT-LIABILITIES>                          847,309
<BONDS>                                              0
                                0
                                    185,242
<COMMON>                                     4,602,735
<OTHER-SE>                                 (1,586,138)
<TOTAL-LIABILITY-AND-EQUITY>                 4,049,148
<SALES>                                      2,658,914
<TOTAL-REVENUES>                             2,658,914
<CGS>                                        1,765,669
<TOTAL-COSTS>                                1,765,669
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                               8,171
<INCOME-PRETAX>                              (141,282)
<INCOME-TAX>                                       800
<INCOME-CONTINUING>                          (142,082)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                 (142,082)
<EPS-BASIC>                                      (.07)
<EPS-DILUTED>                                    (.07)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission